CCR2 and neoplasm: In fact, inhibition of CXCR2 and CCR2 could reverse tumor progression promoted by type I collagen deletion in myCAFs as was evident in a PDAC mouse model potentially by cytotoxic T cell trafficking (Chen Y. et al., 2021).